Company Overview - Exagen Inc. is a leading provider of autoimmune diagnostics, focused on transforming care for patients with chronic autoimmune conditions [4] - The company's flagship product, AVISE CTD, aids in the early and accurate diagnosis of complex autoimmune diseases such as lupus, rheumatoid arthritis, and Sjögren's syndrome [4] - Exagen specializes in testing for rheumatic diseases, offering a comprehensive suite of AVISE-branded tests for diagnosis, prognosis, and monitoring [4] Upcoming Events - Management will participate in the BTIG at Snowbird conference on February 11, 2025, with one-on-one investor meetings scheduled [1] - At the TD Cowen's 45th Annual Health Care Conference, management will engage in a fireside chat on March 5, 2025, and will also hold one-on-one investor meetings [2] - The 5th Annual KeyBanc Capital Markets Healthcare Forum will see management participating virtually in a fireside chat and one-on-one meetings on March 18, 2025 [3]
Exagen Inc. to Participate in Upcoming Investor Conferences